
NASDAQ:NUTX
This summary was created by AI, based on 2 opinions in the last 12 months.
Nutex Health Inc. (NUTX-Q) is a growing company that specializes in operating micro-hospitals across the United States. The latest analysis from Stockchase Research indicates that despite past performance leading to a stop at $126, its prospects remain promising. Analysts forecast an impressive annual EPS growth rate of over 30% for the next five years, highlighting a strong runway for expansion. With the stock trading at 8 times earnings and demonstrating robust financial metrics, including a 63% return on equity and growing cash reserves, it appears well-positioned. However, analysts advise covering positions at this time to maintain discipline amidst market fluctuations, while also indicating a potential upside to $204 and a price target of $250.
Nutex Health Inc. is a American stock, trading under the symbol NUTX (previously NUTX-Q on Stockchase) on the NASDAQ (NUTX). It is usually referred to as NASDAQ:NUTX or NUTX
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on NUTX (previously NUTX-Q on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is PAST TOP PICK. Read the latest stock experts' ratings for Nutex Health Inc..
Nutex Health Inc. was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2026-02-05. Read the latest stock experts ratings for Nutex Health Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Nutex Health Inc..
Nutex Health Inc. is followed by 7 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-04, Nutex Health Inc. (NUTX) stock closed at a price of $193.24.
Our PAST TOP PICK with NUTX has triggered its stop at $126. To remain disciplined, we recommend covering the position at this time.